中百集團(000759.SZ):與永輝超市簽訂《湖北省參股股權轉讓產權交易合同》
格隆匯6月5日丨中百集團(000759.SZ)公佈,4月15日,公司收到武漢光谷聯合產權交易所江城產權交易有限公司(以下簡稱“武漢光谷聯交所”)《信息發佈申請受理通知書》,武漢光谷聯交所同意受理公司公開掛牌轉讓永輝中百45%的股權項目的信息發佈申請,公開掛牌轉讓底價為10萬元,掛牌起始日期為2024年4月16日,掛牌公吿期為20個工作日。截止掛牌公吿期滿,公司收到武漢光谷聯交所通知,僅有永輝超市股份有限公司(簡稱“永輝超市”)一家意向受讓方報名參與競買,擬受讓價格為10萬元。2024年6月5日,公司與永輝超市簽訂了《湖北省參股股權轉讓產權交易合同》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.